Patients with the CPT Hip System Femoral Stem 12/14 ... Analyst Upgrade Amid Promising Growth From New Products, Demographic ...

The highly-anticipated Z1 Femoral Hip System ... statements concerning Zimmer Biomet's expectations, plans, prospects, and product and service offerings, including new product launches and ...

Zimmer Biomet had a strong 2024, bolstering its product lines and staying on top of orthopedic medtech trends.

Citi opened a “90-day positive catalyst watch” on shares of Zimmer Biomet (ZBH) while keeping a Neutral rating on the name with a $120 price ...

The manufacturer of orthopedic medtech products is getting its message ... who has had a hip replaced, said Zimmer Biomet’s focus on maximizing mobility and improving health “really resonates ...

Medical technology company Zimmer Biomet has received approval from the U.S. Food and Drug Administration for its Oxford cementless partial knee, making it the first implant of its kind available ...

Zimmer Biomet Holdings (ZBH – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Larry ...

Forward-looking statements include, but are not limited to, statements concerning Zimmer Biomet's expectations, plans, prospects, and product and service offerings, including new product launches ...

Zacks Research lowered their Q3 2025 earnings per share (EPS) estimates for shares of Zimmer Biomet in a research note issued on Monday, November 25th. Zacks Research analyst R. Department now expects ...

New developments in hip replacement technology are expected to contribute to future sales growth. These product innovations are crucial for Zimmer Biomet's strategy to grow above-market rates in ...

Company's Booth Spotlights Comprehensive Hip Portfolio and Enabling ... statements concerning Zimmer Biomet's expectations, plans, prospects, and product and service offerings, including new ...

Company's Booth Spotlights Comprehensive Hip Portfolio and Enabling Technologies ... statements concerning Zimmer Biomet's expectations, plans, prospects, and product and service offerings, including ...